MedCity News June 6, 2020
Amid the deepest economic crisis since the Great Depression, it has been reported that startups overall face an “existential threat.” But while life science startups have slimmer pickings than before, they stand to benefit from the industry’s more conservative investment approach.
After years of sustained economic growth, the Covid-19 pandemic suddenly has unleashed an economic catastrophe, with unemployment in the U.S. now reaching levels unseen since the Great Depression, notwithstanding the jobs report Friday that showed a dip in jobless numbers. Amid the crisis, startups also face what one article called an “existential threat” as they may struggle to find funding. But taking a more granular look at life science startups, in particular, reveals a slightly more complicated reality.
In...
Today's Sponsors
Today's Sponsor